Avsnittsbeskrivning
In this episode of Diagnosing Dx, David Filby is joined by Hannah Mamuszka, Founder of Alva10.
After more than 20 years in the diagnostics industry, Hannah has seen first-hand why promising scientific breakthroughs don't always translate into better patient care. The challenge often isn't the science itself, but the financial incentives, reimbursement structures and clinical workflows that determine whether a diagnostic test is actually adopted.
Hannah explains how Alva10 approaches this problem from both sides, working with diagnostic developers and healthcare payers to identify unmet…

